Literature DB >> 17353276

The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.

Sandra Barth1, Jutta Nesper, Philippe A Hasgall, Renato Wirthner, Katarzyna J Nytko, Frank Edlich, Dörthe M Katschinski, Daniel P Stiehl, Roland H Wenger, Gieri Camenisch.   

Abstract

The heterodimeric hypoxia-inducible transcription factors (HIFs) are central regulators of the response to low oxygenation. HIF-alpha subunits are constitutively expressed but rapidly degraded under normoxic conditions. Oxygen-dependent hydroxylation of two conserved prolyl residues by prolyl-4-hydroxylase domain-containing enzymes (PHDs) targets HIF-alpha for proteasomal destruction. We identified the peptidyl prolyl cis/trans isomerase FK506-binding protein 38 (FKBP38) as a novel interactor of PHD2. Yeast two-hybrid, glutathione S-transferase pull-down, coimmunoprecipitation, colocalization, and mammalian two-hybrid studies confirmed specific FKBP38 interaction with PHD2, but not with PHD1 or PHD3. PHD2 and FKBP38 associated with their N-terminal regions, which contain no known interaction motifs. Neither FKBP38 mRNA nor protein levels were regulated under hypoxic conditions or after PHD inhibition, suggesting that FKBP38 is not a HIF/PHD target. Stable RNA interference-mediated depletion of FKBP38 resulted in increased PHD hydroxylation activity and decreased HIF protein levels and transcriptional activity. Reconstitution of FKBP38 expression abolished these effects, which were independent of the peptidyl prolyl cis/trans isomerase activity. Downregulation of FKBP38 did not affect PHD2 mRNA levels but prolonged PHD2 protein stability, suggesting that FKBP38 is involved in PHD2 protein regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353276      PMCID: PMC1899990          DOI: 10.1128/MCB.01324-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.

Authors:  Kenneth K W To; L Eric Huang
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

2.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

Authors:  P C Mahon; K Hirota; G L Semenza
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

3.  Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.

Authors:  E J Soilleux; H Turley; Y M Tian; C W Pugh; K C Gatter; A L Harris
Journal:  Histopathology       Date:  2005-12       Impact factor: 5.087

4.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.

Authors:  N Masson; C Willam; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

7.  Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation.

Authors:  R M Wanner; P Spielmann; D M Stroka; G Camenisch; I Camenisch; A Scheid; D R Houck; C Bauer; M Gassmann; R H Wenger
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

8.  HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.

Authors:  Edurne Berra; Emmanuel Benizri; Amandine Ginouvès; Véronique Volmat; Danièle Roux; Jacques Pouysségur
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor.

Authors:  Maija Hirsilä; Peppi Koivunen; Volkmar Günzler; Kari I Kivirikko; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  40 in total

1.  The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Authors:  Katja Haupt; Günther Jahreis; Miriam Linnert; Mitcheell Maestre-Martínez; Miroslav Malesevic; Arndt Pechstein; Frank Edlich; Christian Lücke
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

2.  Label-Free Interactome Analysis Revealed an Essential Role of CUL3-KEAP1 Complex in Mediating the Ubiquitination and Degradation of PHD2.

Authors:  Ang Luo; Yue Chen
Journal:  J Proteome Res       Date:  2019-12-06       Impact factor: 4.466

3.  The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.

Authors:  Daniel E Foxler; Katherine S Bridge; Victoria James; Thomas M Webb; Maureen Mee; Sybil C K Wong; Yunfeng Feng; Dumitru Constantin-Teodosiu; Thorgunnur Eyfjord Petursdottir; Johannes Bjornsson; Sigurdur Ingvarsson; Peter J Ratcliffe; Gregory D Longmore; Tyson V Sharp
Journal:  Nat Cell Biol       Date:  2012-01-29       Impact factor: 28.824

4.  Loss-of-function zinc finger mutation in the EGLN1 gene associated with erythrocytosis.

Authors:  Margje Sinnema; Daisheng Song; Wei Guan; Johanna W H Janssen; Richard van Wijk; Bradleigh E Navalsky; Kai Peng; Albertine E Donker; Alexander P A Stegmann; Frank S Lee
Journal:  Blood       Date:  2018-08-15       Impact factor: 22.113

5.  The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α.

Authors:  Patrick R Arsenault; Daisheng Song; Yu Jin Chung; Tejvir S Khurana; Frank S Lee
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

6.  FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.

Authors:  Yeshavanth K Banasavadi-Siddegowda; Junbo Mai; Yifei Fan; Sumit Bhattacharya; David R Giovannucci; Edwin R Sanchez; Gunter Fischer; Xiaodong Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

7.  Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.

Authors:  D Trisciuoglio; C Gabellini; M Desideri; Y Ragazzoni; T De Luca; E Ziparo; D Del Bufalo
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

8.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Oxygen sensing in Drosophila: multiple isoforms of the prolyl hydroxylase fatiga have different capacity to regulate HIFalpha/Sima.

Authors:  Julieta M Acevedo; Lazaro Centanin; Andrés Dekanty; Pablo Wappner
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

10.  Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.

Authors:  Francesca Pistollato; Elena Rampazzo; Sara Abbadi; Alessandro Della Puppa; Renato Scienza; Domenico D'Avella; Luca Denaro; Geertruy Te Kronnie; David M Panchision; Giuseppe Basso
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.